Skip to main content
Terug
Watch Compare

MANGOCEUTICALS, INC.

Datakwaliteit: 100%
MGRX
NASDAQ Services Health Services
€ 0,34
€ 0,00 (0,00%)
Marktkapitalisatie: 5,77 M
Prijs
€ 0,35
Marktkapitalisatie
5,77 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -5,85 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-25,96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-118,05%
Onder sectorgemiddelde (-15,95%)
ROIC-81,47%
Net Margin-4526,76%
Op. Margin-3954,28%

Veiligheid

Debt / Equity
N/A
Current Ratio0,74
Interest Coverage-174,20

Waardering

PE (TTM)
-0,28
Boven sectorgemiddelde (-1,17)
P/B Ratio0,37
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (515 peers)
Metriek Aandeel Sector Mediaan
P/E -0,3 -1,2
P/B 0,4 1,4
ROE % -118,1 -16,0
Net Margin % -4526,8 -18,3
Rev Growth 5Y % — 4,0
D/E — 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 — 360.057,76 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25,96% Revenue Growth (3Y) -21,04%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 456.021,0 Net Income (TTM) -20,64 M
ROE -118,05% ROA -110,47%
Gross Margin 54,91% Operating Margin -3954,28%
Net Margin -4526,76% Free Cash Flow (TTM) -5,85 M
ROIC -81,47% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,74
Interest Coverage -174,20 Asset Turnover 0,02
Working Capital -206.052 Tangible Book Value -191.053
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,28 Forward P/E N/A
P/B Ratio 0,37 P/S Ratio 12,65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -101,41%
Market Cap 5,77 M Enterprise Value 5,29 M
Per Share
EPS (Diluted TTM) -2,17 Revenue / Share 0,03
FCF / Share -0,35 OCF / Share -0,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 28,34%
SBC-Adj. FCF -7,16 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 456.021,0 615.873,0 731.493,0
Net Income -20,64 M -8,71 M -9,21 M
EPS (Diluted) -2,17 -4,84 -0,57
Gross Profit 250.386,0 379.964,0 431.501,0
Operating Income -18,03 M -7,97 M -9,22 M
EBITDA — — —
R&D Expenses — — —
SG&A Expenses — — —
D&A — 9.936,0 —
Interest Expense 103.513,0 -6.473,0 6.473,0
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 16,09 M 15,37 M 1,05 M
Total Liabilities 890.568,0 1,43 M 276.039,0
Shareholders' Equity 15,20 M 13,95 M 774.754,0
Total Debt — — —
Cash & Equivalents 1,49 M 58.653,0 739.006,0
Current Assets 1,55 M 75.595,0 818.460,0
Current Liabilities 890.568,0 1,43 M 211.078,0